Press Releases

August 14, 2012

Synthetic Biologics Reports Second Quarter 2012 Financial Results

August 8, 2012

Synthetic Biologics and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases

May 15, 2012

Synthetic Biologics Reports First Quarter 2012 Financial Results

May 14, 2012

Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs

May 11, 2012

Synthetic Biologics Appoints Jeffrey J. Kraws as Independent Chairman

April 26, 2012

Synthetic Biologics Launches Free Investor Relations Mobile Application

April 18, 2012

Synthetic Biologics Appoints Michael Kaleko, M.D., Ph.D., as Scientific Director

March 30, 2012

Synthetic Biologics Reports 2011 Year End Financial Results

March 14, 2012

Synthetic Biologics Announces Completion of Enrollment in 164 Patient Clinical Trial of Oral Trimesta™ for Multiple Sclerosis

March 7, 2012

Synthetic Biologics to Present at ROTH Annual Growth Stock Conference